Nuclear stress tests expose patients to toxic radiation levels. We found 18 percent of physicians order them over 75 percent of the time.
Nuclear stress tests expose patients to toxic radiation levels. We found 18 percent of physicians order them over 75 percent of the time.
Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.
What if your doctor handed out grocery lists, not a grocery list of pills to take?
Navvis and HMSA are ending fee-for-service and moving primary care physicians to value-based payments.
When it comes to health benefits, paying more doesn't always get you more. But, consumers will open up their wallets for better value.
Pharma companies and providers in search of better solutions must look to the patient experience for answers.
A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.
Hospital systems seek sustainability, scale, and relevance. Models that rethink tradition will thrive.
2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.
Despite its unstable global geopolitical climate, Asia is primed for steady change this year in healthcare.
